Lead Product(s) : Afimoxifene
Therapeutic Area : Undisclosed
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 27, 2017
Lead Product(s) : Afimoxifene
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Afimoxifene
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : National Cancer Institute | BHR Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 15, 2016
Lead Product(s) : Afimoxifene
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : National Cancer Institute | BHR Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
